Previous studies showed that blockage of PERK signaling, one of the three arms of UPR, resulted in increased susceptivity of cancer cells to hypoxia and metabolic stress in vitro and tumor growth retardation in vivo11, 12. The gene discussed is EIF2AK3; the disease is cancer.